Clinical Trial Update: Modification of Allergic Immunologic Response by Leukotriene Antagonists - Ancillary to ACRN IMPACT

View source ↗

Summary

A completed clinical trial update examining whether leukotriene antagonists modify allergic immunologic responses, conducted as an ancillary study to ACRN IMPAC…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Leukotriene antagonists (class)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Asthma, Lung Diseases | Status: COMPLETED